Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis

Peter Merkel; Parameswaran Nair; Nader Khalidi; Benjamin Terrier; Bernhard Hellmich; Arnaud Bourdin; David R.W. Jayne; David Jackson; Florence Roufosse; Christian Pagnoux; Ulrich Specks; Lena Börjesson Sjö; Calvin Ho; Maria Jison; Christopher Mccrae; Sofia Necander; Eva Rodríguez-Suárez; Anat Shavit; Claire Walton; Michael Wechsler

doi:10.1016/j.ard.2025.06.2131

Retour

Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis

Article de revue

Open Access

Avec comité de lecture

Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis

Peter Merkel, Parameswaran Nair, Nader Khalidi, Benjamin Terrier, Bernhard Hellmich, Arnaud Bourdin, David R.W. Jayne, David Jackson, Florence Roufosse, Christian Pagnoux, …

Annals of the Rheumatic Diseases

08/2025

DOI: https://doi.org/10.1016/j.ard.2025.06.2131

Fichiers et liens (2)

url

Find in HALAfficher

url

https://doi.org/10.1016/j.ard.2025.06.2131Afficher

Published (Version of record) Ouvrir

Indicateurs

1 Consultations de la notice

See more details

Détails

Titre: Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis
Créateurs - sans rôle: Peter Merkel - University of Pennsylvania
Parameswaran Nair - St. Joseph’s Healthcare Hamilton
Nader Khalidi - St. Joseph’s Healthcare Hamilton
Benjamin Terrier - Université Paris Cité
Bernhard Hellmich - Universitätsklinikum Tübingen
Arnaud Bourdin - Université de Montpellier, Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
David R.W. Jayne
David Jackson - King's College London
Florence Roufosse - Erasmus Hospital
Christian Pagnoux - Mount Sinai Hospital
Ulrich Specks - Mayo Clinic
Lena Börjesson Sjö
Calvin Ho - AstraZeneca
Maria Jison - AstraZeneca
Christopher Mccrae - AstraZeneca
Sofia Necander - AstraZeneca
Eva Rodríguez-Suárez - AstraZeneca
Anat Shavit - AstraZeneca
Claire Walton - AstraZeneca
Michael Wechsler - National Jewish Health
Détails de publication: Annals of the Rheumatic Diseases
Identifiants: 99152586909311
Unité académique: Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
Langue: English
Type de ressource: Journal article
Champs locaux: hal-05206065